UniProt ID | KDM2A_HUMAN | |
---|---|---|
UniProt AC | Q9Y2K7 | |
Protein Name | Lysine-specific demethylase 2A | |
Gene Name | KDM2A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1162 | |
Subcellular Localization | Nucleus, nucleoplasm . Punctate expression throughout the nucleoplasm and enriched in the perinucleolar region. Specifically nucleates at CpG islands where it's presence results in chromatin depleted in H3K36me2. | |
Protein Description | Histone demethylase that specifically demethylates 'Lys-36' of histone H3, thereby playing a central role in histone code. Preferentially demethylates dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36'. May also recognize and bind to some phosphorylated proteins and promote their ubiquitination and degradation. Required to maintain the heterochromatic state. Associates with centromeres and represses transcription of small non-coding RNAs that are encoded by the clusters of satellite repeats at the centromere. Required to sustain centromeric integrity and genomic stability, particularly during mitosis.. | |
Protein Sequence | MEPEEERIRYSQRLRGTMRRRYEDDGISDDEIEGKRTFDLEEKLHTNKYNANFVTFMEGKDFNVEYIQRGGLRDPLIFKNSDGLGIKMPDPDFTVNDVKMCVGSRRMVDVMDVNTQKGIEMTMAQWTRYYETPEEEREKLYNVISLEFSHTRLENMVQRPSTVDFIDWVDNMWPRHLKESQTESTNAILEMQYPKVQKYCLMSVRGCYTDFHVDFGGTSVWYHIHQGGKVFWLIPPTAHNLELYENWLLSGKQGDIFLGDRVSDCQRIELKQGYTFVIPSGWIHAVYTPTDTLVFGGNFLHSFNIPMQLKIYNIEDRTRVPNKFRYPFYYEMCWYVLERYVYCITNRSHLTKEFQKESLSMDLELNGLESGNGDEEAVDREPRRLSSRRSVLTSPVANGVNLDYDGLGKTCRSLPSLKKTLAGDSSSDCSRGSHNGQVWDPQCAPRKDRQVHLTHFELEGLRCLVDKLESLPLHKKCVPTGIEDEDALIADVKILLEELANSDPKLALTGVPIVQWPKRDKLKFPTRPKVRVPTIPITKPHTMKPAPRLTPVRPAAASPIVSGARRRRVRCRKCKACVQGECGVCHYCRDMKKFGGPGRMKQSCVLRQCLAPRLPHSVTCSLCGEVDQNEETQDFEKKLMECCICNEIVHPGCLQMDGEGLLNEELPNCWECPKCYQEDSSEKAQKRKMEESDEEAVQAKVLRPLRSCDEPLTPPPHSPTSMLQLIHDPVSPRGMVTRSSPGAGPSDHHSASRDERFKRRQLLRLQATERTMVREKENNPSGKKELSEVEKAKIRGSYLTVTLQRPTKELHGTSIVPKLQAITASSANLRHSPRVLVQHCPARTPQRGDEEGLGGEEEEEEEEEEEDDSAEEGGAARLNGRGSWAQDGDESWMQREVWMSVFRYLSRRELCECMRVCKTWYKWCCDKRLWTKIDLSRCKAIVPQALSGIIKRQPVSLDLSWTNISKKQLTWLVNRLPGLKDLLLAGCSWSAVSALSTSSCPLLRTLDLRWAVGIKDPQIRDLLTPPADKPGQDNRSKLRNMTDFRLAGLDITDATLRLIIRHMPLLSRLDLSHCSHLTDQSSNLLTAVGSSTRYSLTELNMAGCNKLTDQTLIYLRRIANVTLIDLRGCKQITRKACEHFISDLSINSLYCLSDEKLIQKIS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | PEEERIRYSQRLRGT HHHHHHHHHHHHHHH | 13.54 | 26074081 | |
11 | Phosphorylation | EEERIRYSQRLRGTM HHHHHHHHHHHHHHH | 10.04 | 26074081 | |
17 | Phosphorylation | YSQRLRGTMRRRYED HHHHHHHHHHHHCCC | 10.89 | 26074081 | |
21 (in isoform 5) | Phosphorylation | - | 28.91 | 25159151 | |
22 | Phosphorylation | RGTMRRRYEDDGISD HHHHHHHCCCCCCCH | 23.15 | 29632367 | |
28 | Phosphorylation | RYEDDGISDDEIEGK HCCCCCCCHHHCCCC | 44.53 | 29255136 | |
30 (in isoform 5) | Phosphorylation | - | 52.57 | - | |
36 (in isoform 5) | Phosphorylation | - | 52.02 | - | |
43 | Ubiquitination | RTFDLEEKLHTNKYN EEECHHHHHCCCCCC | 35.87 | - | |
79 | Ubiquitination | LRDPLIFKNSDGLGI CCCCEEEECCCCCCC | 48.85 | 21890473 | |
81 | Phosphorylation | DPLIFKNSDGLGIKM CCEEEECCCCCCCCC | 33.38 | 22210691 | |
104 | Phosphorylation | DVKMCVGSRRMVDVM HEEHHHCCCCEEEEE | 9.05 | 22210691 | |
115 | Phosphorylation | VDVMDVNTQKGIEMT EEEEECCCCHHHHEH | 31.35 | 23532336 | |
180 | Phosphorylation | WPRHLKESQTESTNA CHHHHCCCCCCCCHH | 40.59 | 30576142 | |
182 | Phosphorylation | RHLKESQTESTNAIL HHHCCCCCCCCHHHH | 40.98 | 30576142 | |
185 | Phosphorylation | KESQTESTNAILEMQ CCCCCCCCHHHHHHC | 23.57 | 30576142 | |
193 | Phosphorylation | NAILEMQYPKVQKYC HHHHHHCCHHHHHHE | 12.05 | 30576142 | |
212 (in isoform 2) | Ubiquitination | - | 22.50 | 21890473 | |
386 | Phosphorylation | DREPRRLSSRRSVLT CCCCCCHHHCCHHHC | 21.71 | 17081983 | |
387 | Phosphorylation | REPRRLSSRRSVLTS CCCCCHHHCCHHHCC | 35.98 | 17081983 | |
390 | Phosphorylation | RRLSSRRSVLTSPVA CCHHHCCHHHCCCCC | 21.99 | 25159151 | |
393 | Phosphorylation | SSRRSVLTSPVANGV HHCCHHHCCCCCCCC | 28.91 | 24732914 | |
394 | Phosphorylation | SRRSVLTSPVANGVN HCCHHHCCCCCCCCC | 17.14 | 25159151 | |
404 | Phosphorylation | ANGVNLDYDGLGKTC CCCCCCCCCCCCHHH | 18.31 | 24732914 | |
409 | Acetylation | LDYDGLGKTCRSLPS CCCCCCCHHHHCCHH | 49.87 | 23749302 | |
413 | Phosphorylation | GLGKTCRSLPSLKKT CCCHHHHCCHHHCHH | 46.94 | - | |
416 | Phosphorylation | KTCRSLPSLKKTLAG HHHHCCHHHCHHHCC | 59.10 | 23401153 | |
425 | Phosphorylation | KKTLAGDSSSDCSRG CHHHCCCCCCCCCCC | 30.72 | 28348404 | |
426 | Phosphorylation | KTLAGDSSSDCSRGS HHHCCCCCCCCCCCC | 34.63 | 28348404 | |
427 | Phosphorylation | TLAGDSSSDCSRGSH HHCCCCCCCCCCCCC | 46.73 | 28348404 | |
476 | Ubiquitination | ESLPLHKKCVPTGIE HCCCCCCCCCCCCCC | 29.71 | - | |
505 | Sumoylation | ELANSDPKLALTGVP HHHCCCCCHHHCCCC | 51.92 | 28112733 | |
505 | Sumoylation | ELANSDPKLALTGVP HHHCCCCCHHHCCCC | 51.92 | - | |
518 | Ubiquitination | VPIVQWPKRDKLKFP CCCCCCCCCCCCCCC | 70.98 | 21890473 | |
518 (in isoform 3) | Ubiquitination | - | 70.98 | 21890473 | |
518 (in isoform 1) | Ubiquitination | - | 70.98 | 21890473 | |
526 | Phosphorylation | RDKLKFPTRPKVRVP CCCCCCCCCCCCCCC | 63.84 | - | |
534 | Phosphorylation | RPKVRVPTIPITKPH CCCCCCCCCCCCCCC | 36.21 | 17924679 | |
550 | Phosphorylation | MKPAPRLTPVRPAAA CCCCCCCCCCCCCCC | 22.48 | 29255136 | |
558 | Phosphorylation | PVRPAAASPIVSGAR CCCCCCCCCCCCCHH | 15.50 | 29255136 | |
562 | Phosphorylation | AAASPIVSGARRRRV CCCCCCCCCHHCCCC | 27.70 | 30266825 | |
603 | Phosphorylation | GPGRMKQSCVLRQCL CCCHHHHHHHHHHHH | 10.73 | 28555341 | |
632 | Phosphorylation | EVDQNEETQDFEKKL CCCCCCCCHHHHHHH | 27.53 | 17525332 | |
637 | Acetylation | EETQDFEKKLMECCI CCCHHHHHHHHHHHC | 51.72 | 26051181 | |
692 | Phosphorylation | QKRKMEESDEEAVQA HHHHHHHCHHHHHHH | 36.70 | 29255136 | |
700 | Ubiquitination | DEEAVQAKVLRPLRS HHHHHHHHHHHCCCC | 25.39 | - | |
700 | Acetylation | DEEAVQAKVLRPLRS HHHHHHHHHHHCCCC | 25.39 | 26051181 | |
707 | Phosphorylation | KVLRPLRSCDEPLTP HHHHCCCCCCCCCCC | 33.33 | 30266825 | |
713 | Phosphorylation | RSCDEPLTPPPHSPT CCCCCCCCCCCCCCC | 44.45 | 29255136 | |
718 | Phosphorylation | PLTPPPHSPTSMLQL CCCCCCCCCCCHHHH | 35.33 | 29255136 | |
720 | Phosphorylation | TPPPHSPTSMLQLIH CCCCCCCCCHHHHHC | 29.77 | 29255136 | |
721 | Phosphorylation | PPPHSPTSMLQLIHD CCCCCCCCHHHHHCC | 22.37 | 29255136 | |
731 | Phosphorylation | QLIHDPVSPRGMVTR HHHCCCCCCCCCCCC | 17.80 | 23927012 | |
737 | Phosphorylation | VSPRGMVTRSSPGAG CCCCCCCCCCCCCCC | 18.88 | 30576142 | |
739 | Phosphorylation | PRGMVTRSSPGAGPS CCCCCCCCCCCCCCC | 31.36 | 23401153 | |
740 | Phosphorylation | RGMVTRSSPGAGPSD CCCCCCCCCCCCCCC | 24.86 | 23401153 | |
746 | Phosphorylation | SSPGAGPSDHHSASR CCCCCCCCCCCCCCC | 48.97 | 24732914 | |
750 | Phosphorylation | AGPSDHHSASRDERF CCCCCCCCCCCCHHH | 25.23 | 24732914 | |
752 | Phosphorylation | PSDHHSASRDERFKR CCCCCCCCCCHHHHH | 43.19 | 24732914 | |
768 | Phosphorylation | QLLRLQATERTMVRE HHHHHHHHHHHHHHH | 17.03 | 22210691 | |
781 | Phosphorylation | REKENNPSGKKELSE HHHHCCCCCCCCHHH | 66.42 | 29214152 | |
791 | Acetylation | KELSEVEKAKIRGSY CCHHHHHHHHHCCCE | 61.22 | 12655761 | |
797 | Phosphorylation | EKAKIRGSYLTVTLQ HHHHHCCCEEEEEEE | 13.71 | - | |
798 | Phosphorylation | KAKIRGSYLTVTLQR HHHHCCCEEEEEEEC | 14.82 | 22210691 | |
800 | Phosphorylation | KIRGSYLTVTLQRPT HHCCCEEEEEEECCC | 11.83 | 22210691 | |
802 | Phosphorylation | RGSYLTVTLQRPTKE CCCEEEEEEECCCCH | 16.37 | 28555341 | |
807 | Phosphorylation | TVTLQRPTKELHGTS EEEEECCCCHHCCCC | 39.06 | 22210691 | |
813 | Phosphorylation | PTKELHGTSIVPKLQ CCCHHCCCCCHHCHH | 12.44 | 28555341 | |
814 | Phosphorylation | TKELHGTSIVPKLQA CCHHCCCCCHHCHHH | 26.61 | 28555341 | |
818 | Acetylation | HGTSIVPKLQAITAS CCCCCHHCHHHHHCC | 42.19 | 25953088 | |
823 | Phosphorylation | VPKLQAITASSANLR HHCHHHHHCCCCCCC | 24.41 | 24732914 | |
825 | Phosphorylation | KLQAITASSANLRHS CHHHHHCCCCCCCCC | 22.72 | 27696853 | |
826 | Phosphorylation | LQAITASSANLRHSP HHHHHCCCCCCCCCC | 20.79 | 27696853 | |
832 | Phosphorylation | SSANLRHSPRVLVQH CCCCCCCCCEEEEEE | 14.15 | 25159151 | |
844 | Phosphorylation | VQHCPARTPQRGDEE EEECCCCCCCCCCCC | 26.36 | 26055452 | |
869 | Phosphorylation | EEEEEDDSAEEGGAA HHHHCCCCHHHCCCC | 50.32 | 30175587 | |
883 | Phosphorylation | ARLNGRGSWAQDGDE CCCCCCCCCCCCCCC | 20.20 | 26055452 | |
927 | Acetylation | WYKWCCDKRLWTKID HHHHHCCCCCCCCCC | 35.16 | 26051181 | |
932 | Ubiquitination | CDKRLWTKIDLSRCK CCCCCCCCCCHHHHH | 23.73 | - | |
936 | Phosphorylation | LWTKIDLSRCKAIVP CCCCCCHHHHHHHHH | 31.70 | 30301811 | |
951 | Acetylation | QALSGIIKRQPVSLD HHHHHHHHCCCEEEE | 42.96 | 25953088 | |
951 | Ubiquitination | QALSGIIKRQPVSLD HHHHHHHHCCCEEEE | 42.96 | - | |
988 | Phosphorylation | DLLLAGCSWSAVSAL HHHHCCCCHHHHHHH | 24.13 | - | |
1015 | Ubiquitination | LRWAVGIKDPQIRDL CCHHCCCCCHHHHHH | 58.38 | - | |
1024 | Phosphorylation | PQIRDLLTPPADKPG HHHHHHCCCCCCCCC | 34.23 | 27050516 | |
1029 | Ubiquitination | LLTPPADKPGQDNRS HCCCCCCCCCCCCHH | 53.83 | - | |
1029 | Acetylation | LLTPPADKPGQDNRS HCCCCCCCCCCCCHH | 53.83 | 25953088 | |
1094 | Phosphorylation | AVGSSTRYSLTELNM HHCCCCCCCCEECCC | 14.23 | 20068231 | |
1095 | Phosphorylation | VGSSTRYSLTELNMA HCCCCCCCCEECCCC | 26.06 | 20068231 | |
1097 | Phosphorylation | SSTRYSLTELNMAGC CCCCCCCEECCCCCC | 32.27 | 21955146 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KDM2A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KDM2A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TF65_HUMAN | RELA | physical | 20080798 | |
H32_HUMAN | HIST2H3C | physical | 21251613 | |
SKP1_HUMAN | SKP1 | physical | 15070733 | |
H31T_HUMAN | HIST3H3 | physical | 16362057 | |
UB2G2_HUMAN | UBE2G2 | physical | 21988832 | |
RB_HUMAN | RB1 | physical | 25029110 | |
E2F1_HUMAN | E2F1 | physical | 25029110 | |
IPP2_HUMAN | PPP1R2 | physical | 26344197 | |
STAG2_HUMAN | STAG2 | physical | 26344197 | |
SKP1_HUMAN | SKP1 | physical | 17463251 | |
ATM_HUMAN | ATM | physical | 25823024 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-28; THR-550; SER-558;SER-692 AND SER-869, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-390; SER-394; THR-550;SER-558; SER-692; THR-713; SER-718; SER-721; SER-731; SER-832; THR-844AND SER-869, AND MASS SPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-692, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-550; SER-558; THR-713;SER-718; THR-720; SER-731; SER-739 AND SER-740, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-28, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-632, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-534, AND MASSSPECTROMETRY. |